The largest DNA ancestry service in the world sign in register kit
23andMe provides ancestry-related genetic reports and uninterpreted raw genetic data. We no longer offer our health-related genetic reports. If you are a current customer please go to the health page for more information. Close alert.
23andMe provides ancestry-related genetic reports and uninterpreted raw genetic data. We no longer offer our health-related genetic reports. If you are a current customer please go to the health page for more information. Close alert.

Platform Services

23andMe Products and Services for the Healthcare Industry

Incorporating the 23andMe platform into clinical development enables therapeutic developers to evaluate individualized responses to treatment at large scale, while providing research participants with a truly patient-centric study experience.

Research
Clinical Development
Commercialization

Understand Disease Biology

  • Explore genetics to elucidate disease pathways and identify novel drug targets
  • Utilize large populations of healthy controls to identify protective variants

Accelerate Timelines & Reduce Risks

  • Recruit for clinical studies based on patients' genetics, diagnosis, co-morbidities, and family history
  • Combine genetics with outcomes to inform therapeutic development
  • Identify genetic causes of variation in drug response and side-effects
  • Augment clinical and pharmacogenetic data with cases and controls from 23andMe's database of consented research participants
  • Enrich clinical data with patient-reported outcomes
  • Enable long-term data collection and patient engagement

Deliver Personalized Patient Care

  • Enhance post-marketing surveillance studies with genetic data and real-time outcomes data
  • Drive patient education using online engagement and personalization tools

BETA 23andMe Research Portal

Enrich and accelerate the R&D process with aggregated data from the world's largest, dynamic, genotyped, phenotyped database.

Interrogate massive amounts of genetic and self-reported data

Conduct broad phenotype association studies on genetic variant(s) of interest

Confirm and verify independently identified discoveries and associations through replication analyses


Case Studies

Incorporating the 23andMe platform into clinical development enables therapeutic developers to evaluate individualized responses to treatment at large scale, while providing research participants with a truly patient-centric study experience.

Recruitment of Rare Genotypes

Enrolled a rare cohort with the click of a button

Healthy Super Controls

Healthy super-controls offer insights into protective factors in CNS disease

10,000-Person Genetic Study Conducted in Days

Accelerated study timelines enabled through on-line data collection

For more information please contact bd@23andme.com